Cheryl Robyn Rosenfeld DO FACE, FACP, FSVM, ECNU
Diabetes, Lipid Metabolism, Parathyroid, Thyroid
North Jersey Endocrine Consultants
Join to View Full Profile
3695 Hill Road, Suite 2ANorth Jersey Endocrine Consultants LlcParsippany, NJ 07054
Phone+1 973-625-2121
Fax+1 973-625-8270
Dr. Rosenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cheryl Rosenfeld is an endocrinologist in Parsippany, NJ. She received her medical degree from New York College of Osteopathic Medicine, trained at the Cleveland Clinic and has been in practice for over 20 years. She specializes in general endocrinology and thyroid ultrasound and is experienced in diabetes mellitus, thyroid cancer, and thyroid disease.
Education & Training
Cleveland Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998- Cleveland Clinic FoundationResidency, Internal Medicine, 1992 - 1996
Massapequa General HospitalInternship, Transitional Year, 1991 - 1992- NYIT College Of Osteopathic MedicineClass of 1991
Certifications & Licensure
NJ State License 2000 - 2025
OH State License 1995 - 2021
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus Start of enrollment: 2010 May 01
- Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 4 citationsExpert Roundtable on Continuous Glucose Monitoring.Cheryl Rosenfeld, Thomas Blevins, Grazia Aleppo, Gregory Forlenza, Diana Isaacs
Endocrine Practice. 2022-06-01 - 14 citationsEffectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study.George Grunberger, Cheryl R. Rosenfeld, Bruce W. Bode, Scott D. Abbott, Carla Nikkel
Drugs - Real World Outcomes. 2020-03-01 - 5 citationsCorticosteroid Weaning in Stable Heart Transplant Patients: Guidance by Serum Cortisol Level.David A. Baran, Cheryl Rosenfeld, Mark J. Zucker
Journal of Transplantation. 2018-02-18
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
